| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/24/1993 | WO1993012142A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
| 06/24/1993 | WO1993012127A1 PLATELET GPIIIa P1?A1 AND P1A2¿ EPITOPES, THEIR PREPARATION AND USE |
| 06/24/1993 | WO1993011796A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011778A1 Bifunctional antithrombotic molecules and antithrombotic polypeptides |
| 06/24/1993 | CA2125975A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | CA2124672A1 Cytokines with an upaired cysteine residue and conjugates thereof |
| 06/23/1993 | EP0547689A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a T-cell stimulatory epitope |
| 06/23/1993 | EP0547681A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a lipopeptide |
| 06/23/1993 | EP0547631A2 Antibody expression vector and antibodies produced thereby |
| 06/23/1993 | EP0547059A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies. |
| 06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 06/19/1993 | CA2085084A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope |
| 06/19/1993 | CA2085083A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide |
| 06/18/1993 | EP0597845A4 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2. |
| 06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
| 06/16/1993 | EP0546125A1 Osteogenic factor |
| 06/16/1993 | EP0546124A1 Multidomain hematopoiesis stimulators |
| 06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 06/15/1993 | US5220006 Identification of a suppressor of atherogenic apolipoprotein |
| 06/15/1993 | US5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules |
| 06/15/1993 | US5219566 Immunoprophylactic polypeptides for schistosomiasis |
| 06/15/1993 | CA1319101C Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
| 06/10/1993 | WO1993011236A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 06/10/1993 | WO1993011235A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 06/10/1993 | WO1993011229A1 Novel polypeptides for promoting cell attachment |
| 06/10/1993 | WO1993011161A1 Multivalent antigen-binding proteins |
| 06/10/1993 | CA2121800A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 06/09/1993 | EP0545343A1 Ligand-binding domains of fibroblast growth factor receptors and chimeric proteins containing these domains |
| 06/09/1993 | EP0134242B1 Protective peptide antigen |
| 06/09/1993 | DE4140003A1 DNA encoding low mol.wt. glutaminase - used for glutamine isolation from human tissues or fluids for treating cancer and HIV |
| 06/08/1993 | US5217872 Diagnosing Lymes disease |
| 06/03/1993 | CA2083778A1 Variable region within fibroblast growth factor receptors that confers ligand specificity |
| 06/02/1993 | EP0544293A2 Process for the preparation of biologically active NGF by genetic engineering |
| 06/01/1993 | US5216132 Soluble t-cell antigen receptor chimeric antigens |
| 05/27/1993 | WO1993010242A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 05/27/1993 | WO1993010239A2 Hepatitis-c virus testing |
| 05/27/1993 | WO1993010232A1 Lymphoid cd30-antigen |
| 05/27/1993 | WO1993010229A1 Fusion proteins comprising mgf and il-3 |
| 05/27/1993 | WO1993010152A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
| 05/27/1993 | WO1993010151A1 Receptor for oncostatin m and leukemia inhibitory factor |
| 05/27/1993 | WO1993010150A1 Expression of neurotrophic factors with heterologous prepro regions |
| 05/27/1993 | WO1993010134A1 Ganglioside analogs |
| 05/27/1993 | CA2123213A1 Ganglioside analogs |
| 05/26/1993 | EP0543195A2 Biosynthetic process for the preparation of proteins |
| 05/26/1993 | EP0542970A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
| 05/26/1993 | EP0542892A1 Chimeric neurotrophic factors |
| 05/26/1993 | EP0542863A1 Expression of recombinant polypeptides with improved purification |
| 05/26/1993 | CN1020857C Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses |
| 05/19/1993 | EP0542679A1 Novel hybrid transforming growth factors |
| 05/19/1993 | EP0541645A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 05/19/1993 | EP0343186B1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY $i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5212072 Genetic engineering and DNA sequences |
| 05/18/1993 | US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/13/1993 | WO1993009229A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 05/13/1993 | WO1993009221A1 Targeted delivery of virus vector to mammalian cells |
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993008837A1 Stabilised antibodies |
| 05/13/1993 | WO1993005751A3 Osteogenic proteins in the treatment of bone deseases |
| 05/13/1993 | DE4200043A1 Recombinant CD30 antigen (KI-1) and corresp. nucleic acid - for diagnosis of anaplastic large-cell lymphoma, and for prepn. of antibodies and antisera, in immuno-absorption, etc. |
| 05/12/1993 | EP0540651A1 Endogenously sweetened transgenic plant products |
| 05/12/1993 | EP0540612A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 05/12/1993 | EP0538268A4 Targeted protection from cytotoxins |
| 05/12/1993 | EP0525054A4 Modified heparin binding growth factors |
| 05/12/1993 | EP0160670B1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 05/12/1993 | CA2082450A1 Hybrid transforming growth factors |
| 05/11/1993 | CA1317557C Breast tumor-associated antigen and monoclonal antibodies specific thereto |
| 05/05/1993 | EP0540065A1 Retinoic acid receptor composition |
| 05/05/1993 | EP0539530A1 Purification directed cloning of peptides |
| 05/05/1993 | EP0539455A1 Multivalent anti-cytokine immunoglobulins |
| 05/05/1993 | EP0539395A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
| 05/05/1993 | EP0515569A4 Calcium channel compositions and methods |
| 05/05/1993 | EP0491867A4 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 05/05/1993 | EP0486526A4 Tumour necrosis factor binding ligands |
| 05/04/1993 | US5208218 T cell growth factor glycoproteins |
| 05/01/1993 | CA2054608A1 Fusion proteins comprising gm-csf and il-3 |
| 04/29/1993 | WO1993008280A1 Recombitope peptides |
| 04/28/1993 | EP0538430A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination |
| 04/28/1993 | EP0538273A1 Alveolar surfactant proteins |
| 04/28/1993 | EP0538268A1 Targeted protection from cytotoxins |
| 04/28/1993 | EP0453456B1 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them |
| 04/21/1993 | EP0537489A1 Monoclonal antibodies against tumor-associated antigens, method for their preparation and their use |
| 04/21/1993 | EP0537293A1 Ligand for cd28 receptor on b cells and methods |
| 04/20/1993 | US5204449 Carriers; drug delivery; veterinary medicine; target specificity; antifertility agents; animal growth regulators monoclonal antibodies; vaccines |
| 04/20/1993 | US5204446 Polypeptide having immunoreactivity with antibody specific to hepatitis b virus |
| 04/15/1993 | WO1993007286A1 Recombinant immunotoxins |
| 04/15/1993 | WO1993007174A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
| 04/15/1993 | WO1993007169A1 Peptide inhibitors of platelet adhesion |
| 04/15/1993 | WO1993006844A1 Hormone analogs with multiple ctp extensions |
| 04/15/1993 | CA2120622A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
| 04/14/1993 | EP0536335A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
| 04/14/1993 | EP0313651B1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 04/13/1993 | US5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
| 04/13/1993 | US5202257 Pure DNA which is capable of hybridizing with receptor polynucleotides under mild conditions |
| 04/13/1993 | US5202247 Hybrid protein containing polypeptide fused to substrate binding region of amino acid sequence |
| 04/13/1993 | US5202239 Expression of recombinant polypeptides with improved purification |
| 04/13/1993 | CA1316133C Method of using bar1 for secreting foreign proteins |
| 04/07/1993 | EP0535088A1 Chimeric toxins with improved inter-domain geometry |